Lugenica’s patent-pending process can reduce the time and cost of drug development by up to 40%

 Lugenica’s platform involves a cutting-edge knowledge engineering process, integrating multiomics and a unique AI methodology, utilizing multidimensional digital twins and real-world data to tackle intricate issues.